Metastatic colorectal cancer outcome and fatty liver disease

Antoine Brouquet; Bernard Nordlinger

doi:10.1038/nrgastro.2013.53

Metastatic colorectal cancer outcome and fatty liver disease

Nat Rev Gastroenterol Hepatol. 2013 May;10(5):266-7. doi: 10.1038/nrgastro.2013.53. Epub 2013 Apr 9.

Authors

Antoine Brouquet¹, Bernard Nordlinger

Affiliation

¹ Department of General Surgery, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris 78, Rue du Général Leclerc, 94275 Le Kremlin-Bicêtre, France.

PMID: 23567218
DOI: 10.1038/nrgastro.2013.53

Abstract

Various factors are reported to affect the risk of local recurrence after resection of colorectal liver metastases. This article discusses the findings of a recent study that investigated the effect of fatty liver disease on the risk of recurrence.

MeSH terms

Antineoplastic Agents / adverse effects*
Antineoplastic Agents / therapeutic use
Colorectal Neoplasms / drug therapy
Colorectal Neoplasms / secondary*
Fatty Liver / chemically induced*
Fatty Liver / epidemiology
Global Health
Humans
Incidence
Risk Factors

Substances

Antineoplastic Agents